Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-30 @ 2:39 AM
Study NCT ID:
NCT07418034
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-18
First Post:
2026-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Sponsor:
University of Maryland, Baltimore
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2031-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-05
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-10
First Submit QC Date:
None
Study First Post Date:
2026-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-10
Last Update Post Date:
2026-02-18
Last Update Post Date Type:
ACTUAL